GB0620661D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB0620661D0
GB0620661D0 GBGB0620661.9A GB0620661A GB0620661D0 GB 0620661 D0 GB0620661 D0 GB 0620661D0 GB 0620661 A GB0620661 A GB 0620661A GB 0620661 D0 GB0620661 D0 GB 0620661D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0620661.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmasol Ltd
Original Assignee
Pharmasol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmasol Ltd filed Critical Pharmasol Ltd
Priority to GBGB0620661.9A priority Critical patent/GB0620661D0/en
Publication of GB0620661D0 publication Critical patent/GB0620661D0/en
Priority to EP07824851A priority patent/EP2081574A1/en
Priority to CA002666581A priority patent/CA2666581A1/en
Priority to PCT/GB2007/050639 priority patent/WO2008047163A1/en
Priority to CNA2007800387417A priority patent/CN101573116A/en
Priority to AU2007311621A priority patent/AU2007311621A1/en
Priority to GB0905120A priority patent/GB2456434A/en
Priority to ZA200902123A priority patent/ZA200902123B/en
Priority to IL197908A priority patent/IL197908A0/en
Priority to US12/386,507 priority patent/US20090270438A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
GBGB0620661.9A 2006-10-18 2006-10-18 Novel compounds Ceased GB0620661D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB0620661.9A GB0620661D0 (en) 2006-10-18 2006-10-18 Novel compounds
AU2007311621A AU2007311621A1 (en) 2006-10-18 2007-10-17 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
CNA2007800387417A CN101573116A (en) 2006-10-18 2007-10-17 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
CA002666581A CA2666581A1 (en) 2006-10-18 2007-10-17 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
PCT/GB2007/050639 WO2008047163A1 (en) 2006-10-18 2007-10-17 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
EP07824851A EP2081574A1 (en) 2006-10-18 2007-10-17 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
GB0905120A GB2456434A (en) 2006-10-18 2009-03-25 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
ZA200902123A ZA200902123B (en) 2006-10-18 2009-03-26 Buprenorphine-containing non-pressurized spray composition for transmucosal administration
IL197908A IL197908A0 (en) 2006-10-18 2009-04-05 Buprenorphine-containing non-pressurised spray composition for transmucosal administration
US12/386,507 US20090270438A1 (en) 2006-10-18 2009-04-17 Novel compositions and formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0620661.9A GB0620661D0 (en) 2006-10-18 2006-10-18 Novel compounds

Publications (1)

Publication Number Publication Date
GB0620661D0 true GB0620661D0 (en) 2006-11-29

Family

ID=37507923

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB0620661.9A Ceased GB0620661D0 (en) 2006-10-18 2006-10-18 Novel compounds
GB0905120A Withdrawn GB2456434A (en) 2006-10-18 2009-03-25 Buprenorphine-containing non-pressurised spray composition for transmucosal administration

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB0905120A Withdrawn GB2456434A (en) 2006-10-18 2009-03-25 Buprenorphine-containing non-pressurised spray composition for transmucosal administration

Country Status (8)

Country Link
EP (1) EP2081574A1 (en)
CN (1) CN101573116A (en)
AU (1) AU2007311621A1 (en)
CA (1) CA2666581A1 (en)
GB (2) GB0620661D0 (en)
IL (1) IL197908A0 (en)
WO (1) WO2008047163A1 (en)
ZA (1) ZA200902123B (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8852638B2 (en) 2005-09-30 2014-10-07 Durect Corporation Sustained release small molecule drug formulation
KR101329496B1 (en) 2006-07-21 2013-11-13 바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 Transmucosal delivery devices with enhanced uptake
GB2461681A (en) * 2008-04-17 2010-01-13 Pharmasol Ltd Buprenorphine liquid spray formulation with solvent and antioxidant
CN101801415B (en) 2007-05-25 2015-09-23 Rb医药品有限公司 The sustained delivery formulations of risperidone compounds
WO2010072398A2 (en) * 2008-12-22 2010-07-01 Boehringer Ingelheim Limited Veterinary formulations
US9272044B2 (en) 2010-06-08 2016-03-01 Indivior Uk Limited Injectable flowable composition buprenorphine
GB2481017B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
GB2481728B (en) * 2010-06-30 2012-05-23 Londonpharma Ltd Formulations and delivery devices for the sublingual administration of opioids
KR20190110628A (en) * 2011-12-21 2019-09-30 바이오딜리버리 사이언시스 인터내셔널 인코포레이티드 Transmucosal drug delivery devices for use in chronic pain relief
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
GB201404139D0 (en) 2014-03-10 2014-04-23 Rb Pharmaceuticals Ltd Sustained release buprenorphine solution formulations
CN108463214A (en) 2015-10-27 2018-08-28 因塞斯发展股份有限公司 liquid buprenorphine formulation

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1296649A2 (en) * 2000-06-22 2003-04-02 Pharmasol Limited Pharmaceutical compositions comprising an opioid analgesic
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Molecular Delivery Corporation Delivery of drug esters through an inhalation route
WO2004071491A1 (en) * 2003-02-04 2004-08-26 Chrysalis Technologies Incorporated Aerosol formulations and aerosol delivery of buspirone, buprenorphine, triazolam, cyclobenzaprine and zolpidem
HUE026152T2 (en) * 2004-04-23 2016-05-30 Philip Morris Products Sa Aerosol generators and methods for producing aerosols

Also Published As

Publication number Publication date
EP2081574A1 (en) 2009-07-29
GB2456434A (en) 2009-07-22
GB0905120D0 (en) 2009-05-06
WO2008047163A1 (en) 2008-04-24
AU2007311621A1 (en) 2008-04-24
ZA200902123B (en) 2010-04-28
CN101573116A (en) 2009-11-04
IL197908A0 (en) 2009-12-24
CA2666581A1 (en) 2008-04-24

Similar Documents

Publication Publication Date Title
GB0620661D0 (en) Novel compounds
EP2034838A4 (en) Novel compounds
EP2032142A4 (en) Novel compounds
EP1981596A4 (en) Novel compounds
GB0603550D0 (en) Novel compounds
GB0609962D0 (en) Novel compounds
EP1981900A4 (en) Novel compounds
GB0605462D0 (en) Novel compounds
GB0602900D0 (en) Novel Compounds
GB0609117D0 (en) Novel compounds
GB0609963D0 (en) Novel compounds
EP2031965A4 (en) Novel compounds
GB0600483D0 (en) Novel compounds
GB0609252D0 (en) Novel sytoprotective compounds
GB0608452D0 (en) Novel compounds
GB0607892D0 (en) Novel compounds
GB0602800D0 (en) Novel Compounds
GB0601305D0 (en) Novel compounds
GB0602133D0 (en) Novel compounds
GB0609071D0 (en) Novel compounds
GB0602237D0 (en) Novel compounds
GB0602238D0 (en) Novel compounds
GB0608978D0 (en) Novel compounds
GB0608976D0 (en) Novel compounds
GB0601728D0 (en) Novel Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)